Conquest Hospital is a National Health Service hospital in St Leonards-on-Sea in Hastings in East Sussex, England. It is managed by the East Sussex Healthcare NHS Trust.

There are 418 beds in Conquest Hospital.

During the past decade, Conquest Hospital conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Conquest Hospital" #1 sponsor was "Institute of Cancer Research, United Kingdom" with 2 trials, followed by "Cancer Research UK" with 1 trials sponsored, "Leukemia Research Fund" with 1 trials sponsored, "Lisette Nixon" with 1 trials sponsored and "ReCor Medical, Inc." with 1 trials sponsored. Other sponsors include 0 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Conquest Hospital" #1 collaborator was "Medical Research Council" with 1 trials as a collaborator and "Velindre NHS Trust" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Conquest Hospital" are "Breast Cancer" (2 trials), "Leukemia" (2 trials), "Metastatic Cancer" (2 trials), "Prostate Cancer" (2 trials) and "Colorectal Cancer" (1 trials). Many other conditions were trialed in "Conquest Hospital" in a lesser frequency.

Most popular intervention types in "Conquest Hospital" are "Drug" (7 trials), "Biological" (4 trials), "Other" (2 trials), "Procedure" (2 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "capecitabine" (3 trials), "cyclophosphamide" (2 trials), "fludarabine phosphate" (2 trials), "fluorouracil" (2 trials) and "ibandronate sodium" (2 trials). Other intervention names were less common.

The vast majority of trials in "Conquest Hospital" are 10 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Conquest Hospital". undefined are not yet recruiting, undefined are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in Conquest Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Conquest Hospital, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 8 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".